Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on GRAFENIA PLC. We currently have 37 research reports from 3 professional analysts.
|24Feb17 07:00||RNS||Director/PDMR Sharedealing|
|24Feb17 07:00||RNS||Employee Share Scheme|
|21Feb17 07:00||RNS||Trading update|
|08Dec16 10:45||RNS||Holding(s) in Company|
|16Nov16 15:08||RNS||Director/PDMR Shareholding|
|09Nov16 12:24||RNS||Directors' Dealings|
Frequency of research reports
Research reports on
N+1 Singer - Morning Song 21-02-2017
21 Feb 17
Abzena (ABZA LN) Contract bookings strong; US costs higher than expected | City of London Investment Group (CLIG LN) Earnings and interim dividend in line, some modest growth in FuM | dotdigital Group (DOTD LN) Good H1; broadening avenues of growth | Grafenia (GRA LN) Weak print volumes | Vernalis (VER LN) Interims highlight increasing Tuzistra™ scrip volume
N+1 Singer - Grafenia - Weak print volumes
21 Feb 17
Trading conditions are still challenging and management remains cautious on the outlook. The new initiatives continue to progress, however, weak print volumes in January and early February has led us to reduce our LBT forecast from £0.3m to £0.6m. We continue to forecast net cash on the balance sheet (c.£0.6m by the year end). A further update is expected in April.
Small Cap Breakfast
16 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - Morning Song 08-11-2016
08 Nov 16
BBA Aviation (BBA LN) Trading in line; Positive bolt-on | EMIS Group (EMIS LN) Shares oversold, fundamentals intact | First Derivatives (FDP LN) Moving into retail analytics | Grafenia (GRA LN) Conditions remain tough | PCI-PAL (PCIP LN) Special dividend confirmed | Trifast (TRI LN) Another strong performance; forecasts upgraded
N+1 Singer - Morning Song 14-10-2016
14 Oct 16
Applied Graphene Materials (AGM LN) First production order | Carclo (CAR LN) Complementary acquisition; trading in line | Grafenia (GRA LN) Conditions challenging; trading improving | Oxford BioMedica (OXB LN) Forecasts updated, upgrade to Hold | Thin Film Electronics ASA (THIN NO) Acquisition of high volume manufacturing capability is milestone event
21 Feb 17
Lighthouse Group* (LGT): Middle Britain growth (CORP) | Utilitywise* (UTW): Double-digit sales growth (CORP) | Trakm8* (TRAK): Earnings expectations cut again (CORP) | dotDigital* (DOTC): Myriad growth opportunities (CORP) | Artilium* (ARTA): Five-year Telenet deal secured and prepaid (CORP) | Netcall* (NET): Cloud investment pays off (CORP)
Time to go over weight
24 Feb 17
We believe equity investors are taking an unnecessarily cautious stance on the construction sector. Forward looking indicators (e.g. consumer confidence, construction PMIs and housing starts) point to a stable market and recent sales LFL are particularly encouraging (e.g. Marshalls). Near term margins may suffer temporary distortions as inflationary pressures build. However, history has shown that modest input cost inflation is actually a positive for earnings growth in the sector. Therefore, as we move into 2018, margin trends are likely to surprise on the upside.
N+1 Singer - Morning Song 22-02-2017
22 Feb 17
CORETX (COR LN) Contract wins and new Lifestyle facility | Gooch & Housego (GHH LN) Solid Q1 trading plus earnings enhancing acquisition of StingRay Optics | NCC Group (NCC LN) Further issues in Assurance | PCI-PAL (PCIP LN) Strong H1 underpins positive outlook | UBM (UBM LN) Results | Verona Pharma (VRP LN) Phase IIa RPL554 add-on trial to tiotropium commenced
N+1 Singer - Morning Song 23-02-2017
23 Feb 17
Genus (GNS LN) Interim results: R&D step-up, disappointing ABS performance | Howden Joinery Group (HWDN LN) Prelims and net cash better than expected but conditions weaken | Oxford Pharmascience Group (OXP LN) Encouraging interim OXPzero™ Ibuprofen exploratory PK data | StatPro Group (SOG LN) Increased majority shareholding in Infovest Consulting | Wilmington Group (WIL LN) Interims slightly ahead, move to focus on 3 verticals
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
Encouraging trading update, boosted by FX
23 Feb 17
The group recently announced an encouraging trading update, with FY results now expected to be slightly above previous expectations, based on solid underlying trading and boosted by ongoing FX tailwinds. As such, we are modestly increasing our forecasts, with an 8.8% increase in EPS for the current year and 9.3% for 2018. This places the shares on a P/E of 16.9x in 2018. We raise our price target from 176p to 215p and, with modest upside from current levels, we maintain our Buy rating.